Fundraising Fox

Sprout2

Raleigh, US · Founded 2017 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

MH
Margaret HenryExecutive Officer
CE
Cynthia EckertExecutive Officer, Director
AO
Adele OlivaDirector
EA
Eric AtkinsExecutive Officer
CW
Cynthia WhiteheadExecutive Officer, Director
SM
Sandra McGlothlinDirector
WR
W. Robert DahlDirector
GB
Gail BeckerDirector
RW
Robert WhiteheadDirector

Investors · 1

1315 CapitalreportedPhiladelphia · $5M – $40Mvia Adele C. Oliva · board

Reported raises · per SEC filings

Form D private placements
▶$10.6MraisedDec 2024 · 51 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandra McGlothlinDirector
  • Margaret HenryExecutive Officer
  • W. Robert DahlDirector
  • Gail BeckerDirector
  • Cynthia EckertExecutive Officer, Director
  • Robert WhiteheadDirector
Offering amount
$12M
Amount sold
$10.6M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedApr 2023 · 43 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia EckertExecutive Officer, Director
  • Robert WhiteheadDirector
  • Gail BeckerDirector
  • Sandra McGlothlinDirector
  • Matthew PetzoldExecutive Officer
  • W. Robert DahlDirector
Offering amount
$10M
Amount sold
$7.1M
Proceeds to insiders
$550K
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28MraisedAug 2022 · 91 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • W. Robert DahlDirector
  • Gail BeckerDirector
  • Matthew PetzoldExecutive Officer
  • Robert WhiteheadDirector
  • Sandra McGlothlinDirector
  • Cynthia EckertExecutive Officer, Director
Offering amount
$30M
Amount sold
$28M
Proceeds to insiders
$1.6M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.9MraisedAug 2019 · 110 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric AtkinsExecutive Officer
  • W. Robert DahlDirector
  • Cynthia EckertExecutive Officer, Director
  • Robert WhiteheadDirector
  • Adele OlivaDirector
Offering amount
$20M
Amount sold
$15.9M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJan 2018 · 203 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Adele OlivaDirector
  • Eric AtkinsExecutive Officer
  • Robert DahlDirector
  • Cynthia WhiteheadExecutive Officer, Director
  • Robert WhiteheadExecutive Officer, Director
Offering amount
$6.6M
Amount sold
$4.5M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.